Cargando…

Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2

[Image: see text] Protective antigen (PA) mediates entry of edema factor (EF) and lethal factor (LF) into the cytoplasmic space of the cells through the formation of a membrane-spanning pore. To do this, PA must initially bind to a host cellular receptor. Recent mass spectrometry analysis of PA usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullangi, Vennela, Mamillapalli, Sireesha, Anderson, David J., Bann, James G., Miyagi, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179592/
https://www.ncbi.nlm.nih.gov/pubmed/25186975
http://dx.doi.org/10.1021/bi500718g
_version_ 1782337118741200896
author Mullangi, Vennela
Mamillapalli, Sireesha
Anderson, David J.
Bann, James G.
Miyagi, Masaru
author_facet Mullangi, Vennela
Mamillapalli, Sireesha
Anderson, David J.
Bann, James G.
Miyagi, Masaru
author_sort Mullangi, Vennela
collection PubMed
description [Image: see text] Protective antigen (PA) mediates entry of edema factor (EF) and lethal factor (LF) into the cytoplasmic space of the cells through the formation of a membrane-spanning pore. To do this, PA must initially bind to a host cellular receptor. Recent mass spectrometry analysis of PA using histidine hydrogen–deuterium exchange (His-HDX) has shown that binding of the von Willebrand factor A (vWA) domain of the receptor capillary morphogenesis protein-2 (CMG2) lowers the exchange rates of the imidazole C(2) hydrogen of several histidines, suggesting that receptor binding decreases the structural flexibility of PA. Here, using His-HDX and fluorescence as a function of denaturant, and protease susceptibility, we show that binding of the vWA domain of CMG2 largely increases the stability of PA and the effect reaches up to 70 Å from the receptor binding interface. We also show that the pK(a) values and HDX rates of histidines located in separate domains change upon receptor binding. These results indicate that when one end of the protein is anchored, the structure of PA is tightened, noncovalent interactions are strengthened, and the global stability of the protein increases. These findings suggest that CMG2 may be used to stabilize PA in future anthrax vaccines.
format Online
Article
Text
id pubmed-4179592
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-41795922015-09-03 Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2 Mullangi, Vennela Mamillapalli, Sireesha Anderson, David J. Bann, James G. Miyagi, Masaru Biochemistry [Image: see text] Protective antigen (PA) mediates entry of edema factor (EF) and lethal factor (LF) into the cytoplasmic space of the cells through the formation of a membrane-spanning pore. To do this, PA must initially bind to a host cellular receptor. Recent mass spectrometry analysis of PA using histidine hydrogen–deuterium exchange (His-HDX) has shown that binding of the von Willebrand factor A (vWA) domain of the receptor capillary morphogenesis protein-2 (CMG2) lowers the exchange rates of the imidazole C(2) hydrogen of several histidines, suggesting that receptor binding decreases the structural flexibility of PA. Here, using His-HDX and fluorescence as a function of denaturant, and protease susceptibility, we show that binding of the vWA domain of CMG2 largely increases the stability of PA and the effect reaches up to 70 Å from the receptor binding interface. We also show that the pK(a) values and HDX rates of histidines located in separate domains change upon receptor binding. These results indicate that when one end of the protein is anchored, the structure of PA is tightened, noncovalent interactions are strengthened, and the global stability of the protein increases. These findings suggest that CMG2 may be used to stabilize PA in future anthrax vaccines. American Chemical Society 2014-09-03 2014-09-30 /pmc/articles/PMC4179592/ /pubmed/25186975 http://dx.doi.org/10.1021/bi500718g Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Mullangi, Vennela
Mamillapalli, Sireesha
Anderson, David J.
Bann, James G.
Miyagi, Masaru
Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2
title Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2
title_full Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2
title_fullStr Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2
title_full_unstemmed Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2
title_short Long-Range Stabilization of Anthrax Protective Antigen upon Binding to CMG2
title_sort long-range stabilization of anthrax protective antigen upon binding to cmg2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179592/
https://www.ncbi.nlm.nih.gov/pubmed/25186975
http://dx.doi.org/10.1021/bi500718g
work_keys_str_mv AT mullangivennela longrangestabilizationofanthraxprotectiveantigenuponbindingtocmg2
AT mamillapallisireesha longrangestabilizationofanthraxprotectiveantigenuponbindingtocmg2
AT andersondavidj longrangestabilizationofanthraxprotectiveantigenuponbindingtocmg2
AT bannjamesg longrangestabilizationofanthraxprotectiveantigenuponbindingtocmg2
AT miyagimasaru longrangestabilizationofanthraxprotectiveantigenuponbindingtocmg2